Clinical Trial Update: Evaluate the Utility of 18FDG-PET as a Tool to Quantify Atherosclerotic Plaque (MK-0000-081 AM3)(COMPLETED) [Phase 1]

View source ↗

Summary

This completed Phase 1 trial evaluates the utility of 18F-FDG PET imaging to quantify atherosclerotic plaque.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Atherosclerotic Vascular Disease | Phase 1 | Status: COMPLETED | Results posted: 2011-11-30